Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
510.00
-64.00 (-11.15%)
Nov 18, 2026, 11:10 AM JST

Kringle Pharma Ratios and Metrics

Millions JPY. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
4,2754,2003,1595,7604,3182,421
Market Cap Growth
42.34%32.96%-45.16%33.41%78.32%-38.21%
Enterprise Value
2,5943,1321,5273,3041,937-27
Last Close Price
574.00501.00462.00847.00798.00450.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
PS Ratio
10.899.5043.8772.0062.586.19
PB Ratio
4.133.602.422.732.140.87
P/TBV Ratio
4.133.602.422.732.140.87
P/OCF Ratio
-----161.42

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
EV/Sales Ratio
7.087.0921.2141.3028.07-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Debt / Equity Ratio
-1.44-1.44-1.24-1.10-1.06-0.99
Asset Turnover
0.220.220.030.030.020.13
Inventory Turnover
0.330.33---0.27
Quick Ratio
9.629.6215.4018.5210.6117.43
Current Ratio
10.7710.7718.8521.5212.5219.80
Return on Equity (ROE)
-65.72%-65.72%-53.65%-36.63%-35.52%-12.50%
Return on Assets (ROA)
-25.09%-25.09%-23.50%-19.00%-19.07%-9.11%
Return on Capital Employed (ROCE)
-45.30%-45.30%-46.10%-31.10%-36.90%-14.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Earnings Yield
-20.63%-19.36%-29.00%-13.13%-19.78%-13.67%
Buyback Yield / Dilution
-12.92%-12.92%-6.92%-18.72%-11.00%-16.91%